Skip to main content

Advertisement

Log in

Leydig-cell tumour of the testis: retrospective analysis of clinical and therapeutic features in 204 cases

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

Leydig-cell tumours (LCT) of the testis are poorly understood clinically. The aim of this report is to analyse the clinical characteristics of LCT in a large patient sample and to compare these findings with corresponding data of germ-cell tumours (GCT).

Methods

In a sample of 208 patients treated during 1995–2017 in 33 institutions, the following characteristics were registered: age, presenting symptoms, primary tumour size, testis-sparing surgery (TSS) or orchiectomy, malignancy, laterality, medical history, and outcome. Data analysis included descriptive statistical methods and logistic regression analysis.

Results

The ratio LCT:GCT is 1:23 (4.4%). The findings are as follows: median age 41 years, undescended testis 8%, bilateral LCTs 3%, malignant LCT 2.5%, contralateral GCT 2.5%, incidental detection 28%, scrotal symptoms 43%, infertility 18%, elevated estradiol levels 29%. TSS was performed in 56% with no local relapse. Of the patients with malignant LCT, one was cured through surgery.

Conclusion

LCT is rare, with a relative frequency (relative to GCT) of 1:23. Malignancy is found in 2.5%. LCT and GCT share a number of clinical features, e.g. bilaterality, history of undescended testis, and presenting age. TSS is safe in benign LCT. Surgery is the treatment of choice in malignant LCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Idrees MT, Ulbright TM, Oliva E, Young RH, Montironi R, Egevad L et al (2017) The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology 70:513–521

    Article  Google Scholar 

  2. Kim I, Young RH, Scully RE (1985) Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol 9:177–192

  3. Di Tonno F, Tavolini IM, Belmonte P, Bertoldin R, Cossaro E, Curti P et al (2009) Lessons from 52 patients with Leydig cell tumor of the testis: the GUONE (North-Eastern Uro-Oncological Group, Italy) experience. Urol Int 82:152–157

    Article  Google Scholar 

  4. Masur Y, Steffens J, Ziegler M, Remberger K (1996) Leydigzell-Tumoren des Hodens—klinische und morphologische Aspekte. Urologe A 35:468–471

    Article  CAS  Google Scholar 

  5. Calleja RK, Rice A, Bullock KN (1999) Unilateral Leydig cell tumour associated with a contralateral undescended testis. BJU Int 83:152

    Article  CAS  Google Scholar 

  6. Dieckmann KP, Loy V (1993) Metachronous germ-cell and Leydig cell tumors of the testis. Do testicular germ cell tumors and Leydig cell tumors share risk factors? Cancer 72:1305–1307

  7. Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM (1998) Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. Am J Surg Pathol 22:1361–1367

    Article  CAS  Google Scholar 

  8. Suardi N, Strada E, Colombo R, Freschi M, Salonia A, Lania C et al (2009) Leydig cell tumour of the testis: presentation, therapy, long-term follow-up and the role of organ-sparing surgery in a single-institution experience. BJU Int 103:197–200

    Article  Google Scholar 

  9. Loeser A, Vergho DC, Katzenberger T, Brix D, Kocot A, Spahn M et al (2009) Testis-sparing surgery versus radical orchiectomy in patients with Leydig cell tumors. Urology 74:370–372

    Article  Google Scholar 

  10. Leonhartsberger N, Pichler R, Stoehr B, Horninger W, Steiner H (2014) Organ-sparing surgery is the treatment of choice in benign testicular tumors. World J Urol 32:1087–1091

    Article  Google Scholar 

  11. Nicolai N, Necchi A, Raggi D, Biasoni D, Catanzaro M, Piva L et al (2015) Clinical outcome in testicular sex cord stromal tumors: testis sparing vs radical orchiectomy and management of advanced disease. Urology 85:402–406

    Article  PubMed Central  Google Scholar 

  12. Bozzini G, Picozzi S, Gadda F, Colombo R, Decobelli O, Palou J et al (2013) Long-term follow-up using testicle-sparing surgery for Leydig cell tumor. Clin Genitourin Cancer 11:321–324

    Article  Google Scholar 

  13. Rothermundt C, Thurneysen C, Cathomas R, Müller B, Mingrone W, Hirschi-Blickenstorfer A et al (2018) Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). Swiss Med Wkly 148:w14640

    Google Scholar 

  14. Dieckmann KP, Richter-Simonsen H, Kulejewski M, Ikogho R, Zecha H, Anheuser P et al (2018) Testicular germ-cell tumours: a descriptive analysis of clinical characteristics at first presentation. Urol Int 100:409–419

    Article  CAS  PubMed Central  Google Scholar 

  15. Ruf CG, Isbarn H, Wagner W, Fisch M, Matthies C, Dieckmann KP (2014) Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. Urol Oncol 32(33):e1–6

    Google Scholar 

  16. Dieckmann KP, Hartmann JT, Classen J, Lüdde R, Diederichs M, Pichlmeier U (2008) Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis. Br J Cancer 99:1517–1521

    Article  PubMed Central  Google Scholar 

  17. Heer R, Jackson MJ, El-Sherif A, Thomas DJ (2010) Twenty-nine Leydig cell tumors: histological features, outcomes and implications for management. Int J Urol. 17:886–889

    Article  Google Scholar 

  18. Dieckmann KP, Kulejewski M, Pichlmeier U, Loy V (2007) Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy. Eur Urol 51:175–185

    Article  Google Scholar 

  19. Banks K, Tuazon E, Berhane K, Koh CJ, De Filippo RE, Chang A et al (2012) Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics. Front Endocrinol (Lausanne). 3:182. https://doi.org/10.3389/fendo.2012.00182

    Article  Google Scholar 

  20. Heidenreich A, Moul JW, Srivastava S, Engelmann UH (1997) Synchronous bilateral testicular tumour: nonseminomatous germ cell tumours and contralateral benign tumours. Scand J Urol Nephrol 31:389–392

    Article  CAS  Google Scholar 

  21. Dieckmann KP, Becker T, Bauer HW (1987) Testicular tumors: presentation and role of diagnostic delay. Urol Int 42:241–247

    Article  CAS  Google Scholar 

  22. Moul JW (2007) Timely diagnosis of testicular cancer. Urol Clin North Am. 34:109–117

    Article  Google Scholar 

  23. Carmignani L, Salvioni R, Gadda F, Colecchia M, Gazzano G, Torelli T et al (2006) Long-term follow up and clinical characteristics of testicular Leydig cell tumor: experience with 24 cases. J Urol 176:2040–2403

    Article  Google Scholar 

  24. Germa-Lluch JR, Garcia del Muro X, Maroto P, Paz-Ares L, Arranz JA, Guma J et al (2002) Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish germ-cell cancer group (GG). Eur Urol 42:553–563

  25. Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fossa SD (2011) Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7102 Norwegian patients (1953–2007). Int J Cancer 129:2867–2874

    Article  CAS  Google Scholar 

  26. Bandak M, Jørgensen N, Juul A, Lauritsen J, Gundgaard-Kier MG, Mortensen MS et al (2017) Preorchiectomy Leydig cell dysfunction in patients with testicular cancer. Clin Genitourin Cancer 15:e37–e43

    Article  Google Scholar 

  27. Wegner HE, Dieckmann KP, Herbst H, Andresen R, Miller K (1997) Leydig cell tumor—comparison of results of radical and testis-sparing surgery in a single center. Urol Int 59:170–173

    Article  CAS  Google Scholar 

  28. Nason GJ, Redmond EJ, Considine SW, Omer SI, Power D, Sweeney P (2017) The natural history of Leydig cell testicular tumours: an analysis of the National Cancer Registry. Ir J Med Sci 187:323–326

    Article  Google Scholar 

  29. Al-Agha OM, Axiotis CA (2007) An in-depth look at Leydig cell tumor of the testis. Arch Pathol Lab Med 131:311–317

    Google Scholar 

  30. Farkas LM, Székely JG, Pusztai C, Baki M (2000) High frequency of metastatic Leydig cell testicular tumours. Oncology 59:118–121

    Article  CAS  Google Scholar 

  31. Bokemeyer C, Harstrick A, Gonnermann O, Schöber C, Kuczyk M, Poliwoda H et al (1993) Metastatic Leydig cell tumours of the testis: report of four cases and review of the literature. Int J Oncol 2:241–244

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

CGR: project development, data collection, data analysis, manuscript editing. NS: data collection, data analysis, project development. HI: data management, data analysis, manuscript writing. BR: data collection, data analysis, JS: manuscript writing and editing, data management. CDF: project development, data collection. KPD: project development, data collection, data analysis, manuscript writing and editing.

Corresponding author

Correspondence to Christian Guido Ruf.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 23 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruf, C.G., Sanatgar, N., Isbarn, H. et al. Leydig-cell tumour of the testis: retrospective analysis of clinical and therapeutic features in 204 cases. World J Urol 38, 2857–2862 (2020). https://doi.org/10.1007/s00345-020-03079-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-020-03079-1

Keywords

Navigation